Home › Funds › Sapience Investments, LLC › IART

Sapience Investments, LLC position in IART

INTEGRA LIFESCIENCES HLDGS C · Health Care

Sapience Investments, LLC reported holding 1,914 shares of IART (INTEGRA LIFESCIENCES HLDGS C) in its Q1 2026 13F filing — a position valued at US$18K, representing 2.34% of its reported portfolio and ranking #7 among its reported holdings. Sapience Investments, LLC has disclosed IART holdings in 10 of the last 11 reported quarters, going back to Q3 2023.

Latest position (Q1 2026)1.91K sh
Reported value held$18.03K
Portfolio Weight2.34%
First reportedQ3 2023
Last changeReduce
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How Sapience Investments, LLC's IART position evolved

Sapience Investments, LLC first disclosed a stake in IART in Q3 2023 at 245,700 shares (US$9.4M). The position peaked in Q4 2023 at 231,137 shares, worth US$10.1M. Across 10 filings, Sapience Investments, LLC increased the stake 3 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q1 2026) shows 1,914 shares valued at US$18K — a reduction of -45,468 shares quarter over quarter.. Notable position changes include a 53% increase in Q2 2025 (shares rose 17% over the following quarter), a 82% trim in Q3 2025 (shares fell 13% over the following quarter), a 96% trim in Q1 2026 (shares rose 91% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 245.70K $9.38M New
Q4 2023 231.14K $10.07M Reduce
Q1 2024 155.80K $5.52M Reduce
Q3 2024 139.94K $2.54M Reduce
Q4 2024 164.78K $3.74M Add
Q1 2025 142.82K $3.14M Reduce
Q2 2025 218.99K $2.69M Add
Q3 2025 40.00K $573.16K Reduce
Q4 2025 47.38K $588.48K Add
Q1 2026 1.91K $18.03K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IART and 13F data

IART (INTEGRA LIFESCIENCES HLDGS C) is a Health Care company. 25 other funds we track also report a position in IART — the largest reported positions include Rubric Capital Management LP (US$139.3M), PARADIGM CAPITAL MANAGEMENT INC/NY (US$61.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IART

All IART fund holders →

FAQ

How long has Sapience Investments, LLC held IART?

Sapience Investments, LLC has disclosed IART holdings in 10 of the last 11 reported quarters, going back to Q3 2023.

What is Sapience Investments, LLC's current position in IART?

As of Q1 2026, Sapience Investments, LLC holds 1.91K shares of IART (INTEGRA LIFESCIENCES HLDGS C), valued at $18.03K, representing 2.34% of its reported portfolio and ranking #7.

Has Sapience Investments, LLC been buying or selling IART?

In the latest 13F filing (Q1 2026), Sapience Investments, LLC reduced its position in IART. The position peaked in Q4 2023 at 231.14K shares.

Which other funds hold IART?

Other major institutional holders of IART include Rubric Capital Management LP, PARADIGM CAPITAL MANAGEMENT INC/NY, among 25 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.